Chemistry of biologically important synthetic organoselenium compounds

G Mugesh, WW du Mont, H Sies - Chemical reviews, 2001 - ACS Publications
The element selenium was discovered in 1818 by the Swedish chemist Berzelius and was
named after the Greek goddess of the moon, Selene. 1 In biology, selenium was long …

Apoptosis is a critical cellular event in cancer chemoprevention and chemotherapy by selenium compounds

R Sinha, K El-Bayoumy - Current cancer drug targets, 2004 - benthamdirect.com
Epidemiological studies, preclinical investigations and clinical intervention trials support the
role of selenium compounds as potent cancer chemopreventive agents; the dose and the …

Crystal structure of the atypical protein kinase domain of a TRP channel with phosphotransferase activity

H Yamaguchi, M Matsushita, AC Nairn, J Kuriyan - Molecular cell, 2001 - cell.com
Transient receptor potential (TRP) channels modulate calcium levels in eukaryotic cells in
response to external signals. A novel transient receptor potential channel has the ability to …

Organoselenium compounds as potential therapeutic and chemopreventive agents: a review

M Soriano-Garcia - Current medicinal chemistry, 2004 - benthamdirect.com
Selenium is an essential trace element. It is, however toxic at concentration little above
which is required for health. Selenium is incorporated into proteins as selenocysteine, the …

Biologically significant selenium-containing heterocycles

M Ninomiya, DR Garud, M Koketsu - Coordination Chemistry Reviews, 2011 - Elsevier
Selenium represents an essential element for organisms as various diseases can result from
selenium deficiency. As a consequence, selenium-containing heterocycles are of …

Eukaryotic elongation factor 2 kinase as a drug target in cancer, and in cardiovascular and neurodegenerative diseases

R Liu, CG Proud - Acta Pharmacologica Sinica, 2016 - nature.com
Eukaryotic elongation factor 2 kinase (eEF2K) is an unusual protein kinase that regulates
the elongation stage of protein synthesis by phosphorylating and inhibiting its only known …

1-Benzyl-3-cetyl-2-methylimidazolium iodide (NH125) induces phosphorylation of eukaryotic elongation factor-2 (eEF2): a cautionary note on the anticancer …

Z Chen, SM Gopalakrishnan, MH Bui, NB Soni… - Journal of Biological …, 2011 - jbc.org
Eukaryotic elongation factor-2 kinase (eEF2K) relays growth and stress signals to protein
synthesis through phosphorylation and inactivation of eukaryotic elongation factor 2 (eEF2) …

Reaction of lithium aluminum hydride with elemental selenium: Its application as a selenating reagent into organic molecules

H Ishihara, M Koketsu, Y Fukuta… - Journal of the American …, 2001 - ACS Publications
Recently many syntheses of compounds containing selenium have been studied and
reported because of the interesting reactivities1 and their potential pharmaceutical …

Identification and characterization of an inhibitor of eukaryotic elongation factor 2 kinase against human cancer cell lines

S Arora, JM Yang, TG Kinzy, R Utsumi… - Cancer …, 2003 - aacrjournals.org
Recent evidence suggests that the machinery of protein synthesis may provide novel targets
for anticancer drugs. For example, aberrations in protein synthesis are commonly …

Eukaryotic elongation factor-2 kinase (eEF2K) signaling in tumor and microenvironment as a novel molecular target

D Karakas, B Ozpolat - Journal of Molecular Medicine, 2020 - Springer
Eukaryotic elongation factor-2 kinase (eEF2K), an atypical member of alpha-kinase family, is
highly overexpressed in breast, pancreatic, brain, and lung cancers, and associated with …